159 related articles for article (PubMed ID: 38623092)
1. Tempol effect on oxidative and mitochondrial markers in preclinical models for prostate cancer.
Rossetto IMU; Santos FR; da Silva HM; Minatel E; Mesquitta M; Salvador MJ; Montico F; Cagnon VHA
Toxicol Res (Camb); 2024 Apr; 13(2):tfae056. PubMed ID: 38623092
[TBL] [Abstract][Full Text] [Related]
2. Tempol differential effect on prostate cancer inflammation: In vitro and in vivo evaluation.
Rossetto I; Santos F; Kido L; Lamas C; Montico F; Cagnon V
Prostate; 2023 Apr; 83(5):403-415. PubMed ID: 36546327
[TBL] [Abstract][Full Text] [Related]
3. Differential tempol effects in prostatic cancer: angiogenesis and short- and long-term treatments.
Santos FR; Rossetto IMU; Montico F; de Almeida Lamas C; Cagnon VHA
J Mol Histol; 2024 Jun; 55(3):253-264. PubMed ID: 38551737
[TBL] [Abstract][Full Text] [Related]
4. Nintedanib antiangiogenic inhibitor effectiveness in delaying adenocarcinoma progression in Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP).
da Silva RF; Nogueira-Pangrazi E; Kido LA; Montico F; Arana S; Kumar D; Raina K; Agarwal R; Cagnon VHA
J Biomed Sci; 2017 May; 24(1):31. PubMed ID: 28499383
[TBL] [Abstract][Full Text] [Related]
5. The Cyclic Nitroxide TEMPOL Ameliorates Oxidative Stress but Not Inflammation in a Cell Model of Parkinson's Disease.
Leathem A; Simone M; Dennis JM; Witting PK
Antioxidants (Basel); 2022 Jan; 11(2):. PubMed ID: 35204139
[TBL] [Abstract][Full Text] [Related]
6. Tempol improves redox status in mdx dystrophic diaphragm muscle.
Hermes TA; Mizobuti DS; da Rocha GL; da Silva HNM; Covatti C; Pereira ECL; Ferretti R; Minatel E
Int J Exp Pathol; 2020 Dec; 101(6):289-297. PubMed ID: 33098599
[TBL] [Abstract][Full Text] [Related]
7. The nitroxide tempol has similar antioxidant effects as physiological levels of 17beta-oestradiol in reversing ovariectomy-induced oxidative stress in mice liver and kidney.
Enli Y; Oztekin O; Pinarbasili RD
Scand J Clin Lab Invest; 2009; 69(4):526-34. PubMed ID: 19343575
[TBL] [Abstract][Full Text] [Related]
8. Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells.
Ripple MO; Henry WF; Rago RP; Wilding G
J Natl Cancer Inst; 1997 Jan; 89(1):40-8. PubMed ID: 8978405
[TBL] [Abstract][Full Text] [Related]
9. Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat.
Chatterjee PK; Cuzzocrea S; Brown PA; Zacharowski K; Stewart KN; Mota-Filipe H; Thiemermann C
Kidney Int; 2000 Aug; 58(2):658-73. PubMed ID: 10916089
[TBL] [Abstract][Full Text] [Related]
10. Protective Effect of Tempol on Buthionine Sulfoximine-Induced Mitochondrial Impairment in Hippocampal Derived HT22 Cells.
Salvi A; Patki G; Khan E; Asghar M; Salim S
Oxid Med Cell Longev; 2016; 2016():5059043. PubMed ID: 27069531
[TBL] [Abstract][Full Text] [Related]
11. Tempol protects cardiomyocytes from nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity.
Liu Y; Shim E; Nguyen P; Gibbons AT; Mitchell JB; Poirier MC
Toxicol Sci; 2014 May; 139(1):133-41. PubMed ID: 24591154
[TBL] [Abstract][Full Text] [Related]
12. Tempol improves oxidant/antioxidant parameters in testicular tissues of diabetic rats.
Shateri H; Ranjbar A; Kheiripour N; Ghasemi H; Pourfarjam Y; Habibitabar E; Gholami H; Moridi H
Life Sci; 2019 Mar; 221():65-71. PubMed ID: 30738867
[TBL] [Abstract][Full Text] [Related]
13. Increased H(2)O(2) counteracts the vasodilator and natriuretic effects of superoxide dismutation by tempol in renal medulla.
Chen YF; Cowley AW; Zou AP
Am J Physiol Regul Integr Comp Physiol; 2003 Oct; 285(4):R827-33. PubMed ID: 12791586
[TBL] [Abstract][Full Text] [Related]
14. Tempol, a superoxide dismutase mimetic agent, ameliorates cisplatin-induced nephrotoxicity through alleviation of mitochondrial dysfunction in mice.
Ahmed LA; Shehata NI; Abdelkader NF; Khattab MM
PLoS One; 2014; 9(10):e108889. PubMed ID: 25271439
[TBL] [Abstract][Full Text] [Related]
15. Antioxidative Effects of Tempol on Mitochondrial Dysfunction in Diabetic Nephropathy.
Ranjbar A; Kheiripour N; Ghasemi H; Seif Rabiei MA; Dadras F; Khoshjou F
Iran J Kidney Dis; 2018 Mar; 12(2):84-90. PubMed ID: 29507270
[TBL] [Abstract][Full Text] [Related]
16. Piperidine nitroxide Tempol enhances cisplatin-induced apoptosis in ovarian cancer cells.
Wang M; Li K; Zou Z; Li L; Zhu L; Wang Q; Gao W; Wang Y; Huang W; Liu R; Yao K; Liu Q
Oncol Lett; 2018 Oct; 16(4):4847-4854. PubMed ID: 30250550
[TBL] [Abstract][Full Text] [Related]
17. Tempol differently affects cellular redox changes and antioxidant enzymes in various lung-related cells.
Park WH
Sci Rep; 2021 Jul; 11(1):14869. PubMed ID: 34290305
[TBL] [Abstract][Full Text] [Related]
18. Cross-talk between TRPC-1, mTOR, PGC-1α and PPARδ in the dystrophic muscle cells treated with tempol.
Rocha GLD; Rupcic IF; Mizobuti DS; Hermes TA; Covatti C; Silva HNMD; Araujo HN; Lourenço CC; Silveira LDR; Pereira ECL; Minatel E
Free Radic Res; 2022; 56(3-4):245-257. PubMed ID: 35549793
[TBL] [Abstract][Full Text] [Related]
19. Increasing discordant antioxidant protein levels and enzymatic activities contribute to increasing redox imbalance observed during human prostate cancer progression.
Chaiswing L; Zhong W; Oberley TD
Free Radic Biol Med; 2014 Feb; 67():342-52. PubMed ID: 24269899
[TBL] [Abstract][Full Text] [Related]
20. Effects of tempol and redox-cycling nitroxides in models of oxidative stress.
Wilcox CS
Pharmacol Ther; 2010 May; 126(2):119-45. PubMed ID: 20153367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
